Akt and CHIP coregulate tau degradation through coordinated interactions
Open Access
- 4 March 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (9) , 3622-3627
- https://doi.org/10.1073/pnas.0709180105
Abstract
A hallmark of the pathology of Alzheimer9s disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer9s disease.Keywords
This publication has 22 references indexed in Scilit:
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteinsJournal of Clinical Investigation, 2007
- Current strategies for the treatment of Alzheimer’s disease and other tauopathiesEmerging Therapeutic Targets, 2006
- Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau SpeciesJournal of Neuroscience, 2006
- HSP induction mediates selective clearance of tau phosphorylated at proline‐directed Ser/Thr sites but not KXGS (MARK) sitesThe FASEB Journal, 2006
- PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in DrosophilaCell, 2004
- Regulation of Longevity inCaenorhabditis elegansby Heat Shock Factor and Molecular ChaperonesMolecular Biology of the Cell, 2004
- CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregationHuman Molecular Genetics, 2004
- Timing Requirements for Insulin/IGF-1 Signaling in C. elegansScience, 2002
- Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 FunctionJournal of Biological Chemistry, 2002
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995